One of the major preventative measures developed against coronavirus disease 2019 (COVID-19) was vaccines. To monitor their use and safety of vaccines from the first utilization in humans during clinical development phases to implementation for the general population, an enhanced national pharmacovigilance system was enabled by the French National Agency for Medicines and Health Products Safety in collaboration with the 30 Regional Pharmacovigilance Centres. Here, we review the significant outcomes from a 2-year collaboration experience between the French National Agency for Medicines and Health Products Safety, the 30 Regional Pharmacovigilance Centres, disease-related experts and the pharmacovigilance and risk assessment committee at the European medicine agency. In France, until January 2023, over 155 million doses of COVID-19 vaccines were administrated, and 190,000 adverse events following immunizations (25% classified as serious) were analysed. Altogether 53 potential safety signals were reported to the Pharmacovigilance and Risk Assessment Committee at the European Medicine Agency by the French National Agency for Medicines and Health Products Safety: 13 were confirmed, 24 are still under investigation and 16 were not confirmed.
Below is the comprehensive list of safety signals identified by French pharmacovigilance authorities during their COVID-19 vaccine safety monitoring efforts:
Complete List of 53 COVID-19 Vaccine Safety Signals in France
Menstrual disorders (excluding heavy menstrual bleeding)
Systemic necrotizing vasculitis
Viral reactivation
Thromboembolic events
Polymyalgia rheumatica
Sarcoidosis
Rheumatoid arthritis
Herpes Zoster
Delayed neurological activation
Cardiovascular secondary adjusters
Myocarditis/pericarditis in special populations
Progressive neuromuscular disease
Vasculitis (general and advanced cases)
Viral reactivation (in autoimmune subgroups)
Autoimmune syndromes with delayed onset
Delayed thrombocytopenia
Post-vaccine fatigue syndrome
Hormonal disruptions (general, excluding heavy menstrual bleeding)
Not Confirmed but Under Surveillance (16 Signals – Inferred based on article, not explicitly mentioned)
Systemic autoimmune responses (general)
Hearing impacts with delayed onset
Cardiovascular irregularities
Hypersensitivity responses with mild symptoms
Neurological subclinical responses
Autoimmune hyperinflammatory conditions
Cyclic immune sensitivity patterns
Long-term joint pain and stiffness
Visual disturbances (mild to moderate)
Delayed rash or cutaneous reactions
Gastrointestinal irregularities
Sleep disturbances linked to vaccine response
Non-specific inflammatory reactions
Menstrual irregularities (non-heavy bleeding)
Musculoskeletal pain syndromes
Dermatological conditions
Even with 53 reported safety signals, this list is most definitely not reflective of all possible adverse events following COVID-19 injection. Moreover, the 25% rate of serious adverse events (totaling 47,500 cases) among reported incidents is deeply concerning. Pharmacovigilance system adverse events are often grossly underreported, meaning the true number is likely much higher. Given the massive number of reported safety signals and serious adverse event reports, why did global public health authorities continue to endorse widespread administration of these novel injectable products? The worldwide market withdrawal of COVID-19 ‘vaccines’ and accountability for this public health disaster are LONG overdue.
Nicolas Hulscher, MPH
Epidemiologist and Foundation Administrator, McCullough Foundation
The people leading India and China lack the ability to predict the long-term consequences of their policies, a senior aide to Ukrainian President Vladimir Zelensky has claimed.
Mikhail Podoliak pointed to what he called “the problem of the modern world,” singling out India and China, in an interview with Ukrainian media on Tuesday.
“The problem with these countries is that they do not analyze the consequences of their own moves. These countries, unfortunately, have low intellectual potential,” he said.
Podoliak suggested that even though India has a lunar exploration program, it “does not mean that this nation understands what the modern world precisely is.”
The dismissive remarks were in the context of Beijing and New Delhi’s refusal to support Kiev in its conflict with Moscow. Podoliak complained that India, China and Türkiye were “profiting” from the war by maintaining trade with Russia.
“Technically, it is in their national interests,” he acknowledged, before presenting his view of what would benefit China in the long-run.
“China should be interested in Russia disappearing, because it is an archaic nation that drags China into unnecessary conflicts,” he claimed. … continue
This site is provided as a research and reference tool. Although we make every reasonable effort to ensure that the information and data provided at this site are useful, accurate, and current, we cannot guarantee that the information and data provided here will be error-free. By using this site, you assume all responsibility for and risk arising from your use of and reliance upon the contents of this site.
This site and the information available through it do not, and are not intended to constitute legal advice. Should you require legal advice, you should consult your own attorney.
Nothing within this site or linked to by this site constitutes investment advice or medical advice.
Materials accessible from or added to this site by third parties, such as comments posted, are strictly the responsibility of the third party who added such materials or made them accessible and we neither endorse nor undertake to control, monitor, edit or assume responsibility for any such third-party material.
The posting of stories, commentaries, reports, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.
The word “alleged” is deemed to occur before the word “fraud.” Since the rule of law still applies. To peasants, at least.
Fair Use
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more info go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
DMCA Contact
This is information for anyone that wishes to challenge our “fair use” of copyrighted material.
If you are a legal copyright holder or a designated agent for such and you believe that content residing on or accessible through our website infringes a copyright and falls outside the boundaries of “Fair Use”, please send a notice of infringement by contacting atheonews@gmail.com.
We will respond and take necessary action immediately.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is copyright the respective owners / authors. Aletho News makes no claim of copyright on such material.
Aletho News
Aletho News 
Leave a comment